Company / PP&E (Net)
Vera Therapeutics, Inc. PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.4M
FY2025
5-year range
$0 / $1.4M
FY2021-FY2025
Trend
+43.1%
vs FY2024
Sector context
#145 of 193
Health Care
What the data says
Vera Therapeutics, Inc.'s pp&e (net) of $1M is lower than 75% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 4 consecutive years, from $0 in FY2021 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 3-year CAGR of +199.8%.
Improved from $92,000 to $1M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +199.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 193This company $1.4M Sector average $777.6M
▼
-99.8% below sector average
Key checks
Key Insights
- Vera Therapeutics, Inc.'s pp&e (net) has grown for 3 consecutive years.
- 3-year CAGR of +199.8%, indicating consistent growth.
- In FY2025, pp&e (net) increased 43.1% year-over-year.
- Ranks #145 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4M | +43.1% |
| FY2024 | $960.0K | +943.5% |
| FY2023 | $92.0K | +80.4% |
| FY2022 | $51.0K | - |
| FY2021 | $0 | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026